DE2610426C2 - Verwendung eines OEP als Wirkstoff enthaltenden Impfstoffes zur Bekämpfung der durch Pseudomonas aeruginosa hervorgerufenen Pneumonitis der Nerze - Google Patents

Verwendung eines OEP als Wirkstoff enthaltenden Impfstoffes zur Bekämpfung der durch Pseudomonas aeruginosa hervorgerufenen Pneumonitis der Nerze

Info

Publication number
DE2610426C2
DE2610426C2 DE2610426A DE2610426A DE2610426C2 DE 2610426 C2 DE2610426 C2 DE 2610426C2 DE 2610426 A DE2610426 A DE 2610426A DE 2610426 A DE2610426 A DE 2610426A DE 2610426 C2 DE2610426 C2 DE 2610426C2
Authority
DE
Germany
Prior art keywords
oep
mink
pseudomonas aeruginosa
active ingredient
combating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE2610426A
Other languages
German (de)
English (en)
Other versions
DE2610426A1 (de
Inventor
Yuzuru Prof. Homma
Kazuo Prof. Tokio/Tokyo Okada
Takeshi Prof. Shimizu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Tokyo NUC
Original Assignee
University of Tokyo NUC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Tokyo NUC filed Critical University of Tokyo NUC
Publication of DE2610426A1 publication Critical patent/DE2610426A1/de
Application granted granted Critical
Publication of DE2610426C2 publication Critical patent/DE2610426C2/de
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/104—Pseudomonadales, e.g. Pseudomonas
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • C12P1/04—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using bacteria
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/38—Pseudomonas
    • C12R2001/385—Pseudomonas aeruginosa

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE2610426A 1975-03-12 1976-03-12 Verwendung eines OEP als Wirkstoff enthaltenden Impfstoffes zur Bekämpfung der durch Pseudomonas aeruginosa hervorgerufenen Pneumonitis der Nerze Expired DE2610426C2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP50029104A JPS51106714A (https=) 1975-03-12 1975-03-12

Publications (2)

Publication Number Publication Date
DE2610426A1 DE2610426A1 (de) 1976-11-25
DE2610426C2 true DE2610426C2 (de) 1986-03-06

Family

ID=12267023

Family Applications (1)

Application Number Title Priority Date Filing Date
DE2610426A Expired DE2610426C2 (de) 1975-03-12 1976-03-12 Verwendung eines OEP als Wirkstoff enthaltenden Impfstoffes zur Bekämpfung der durch Pseudomonas aeruginosa hervorgerufenen Pneumonitis der Nerze

Country Status (6)

Country Link
US (1) US4083959A (https=)
JP (1) JPS51106714A (https=)
DE (1) DE2610426C2 (https=)
FR (1) FR2303558A1 (https=)
GB (1) GB1538932A (https=)
SE (1) SE7601839L (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4663160A (en) * 1983-03-14 1987-05-05 Miles Laboratories, Inc. Vaccines for gram-negative bacteria
US5124145A (en) * 1989-10-24 1992-06-23 Ciba-Geigy Canada Ltd. Method for the prevention and treatment of bovine mastitis
RU2309767C1 (ru) * 2006-03-20 2007-11-10 Федеральное государственное образовательное учреждение высшего профессионального образования "Кубанский государственный аграрный университет" Способ изготовления вакцины против псевдомоноза свиней
CN102475749B (zh) * 2010-11-23 2013-07-10 贵州大学 治疗奶牛隐性乳房炎的中药透皮剂及其制备方法
CN105670972B (zh) * 2016-03-11 2019-08-09 哈药集团生物疫苗有限公司 水貂绿脓杆菌血清g型菌株及其灭活疫苗和应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3928565A (en) * 1971-10-19 1975-12-23 Yuzuru Homma Pharmaceutical preparation of pseudomonas aeruginosa bacterial component possessing anti-tumor and anti-infection properties
GB1365950A (en) * 1970-10-20 1974-09-04 Eisai Co Ltd Pharmaceutical composition comprising a cell wall protein compo nent of pseudomonas aeruginosa
JPS5140137B2 (https=) * 1971-10-05 1976-11-01

Also Published As

Publication number Publication date
FR2303558A1 (fr) 1976-10-08
GB1538932A (en) 1979-01-24
JPS51106714A (https=) 1976-09-21
FR2303558B1 (https=) 1981-10-23
US4083959A (en) 1978-04-11
DE2610426A1 (de) 1976-11-25
SE7601839L (sv) 1976-09-13

Similar Documents

Publication Publication Date Title
DE3785404T2 (de) Impfstoffe.
DE2610540C2 (de) Verwendung eines OEP als Wirkstoff enthaltenden injizierbaren Impfstoffes zur Vorbeugung gegen die durch Pseudomonas aeruginosa hervorgerufene Pneumonitis der Nerze
DE2610504C2 (de) Eine von Pseudomonas aeruginosa stammende Komponente aus Zucker, Lipoid und Protein, mit Antitumor- und Interferon bildenden Eigenschaften
DE69309915T2 (de) Mycobacterium Vaccae zur Behandlung von langwierigen Autoimmunerkrankungen
DE69316026T2 (de) Als fischimpfstoff anwendbare attenuierte aeromonas salmonicida-stämme
DE2610426C2 (de) Verwendung eines OEP als Wirkstoff enthaltenden Impfstoffes zur Bekämpfung der durch Pseudomonas aeruginosa hervorgerufenen Pneumonitis der Nerze
DE2704766C2 (https=)
DE2823346C2 (de) Verwendung von Glycinderivaten zur Herstellung von antiviriellen Mitteln
DE2655691C2 (de) Temperaturempfindliche, vermehrungsfähige, nicht pathogene Varicella-Zoster-Viren, Verfahren zu ihrer Herstellung und diese Viren enthaltende Lebendvaccine
DE69231724T2 (de) Fischimpfstoff gegen infektion mit aeromonas salmonicida
DE2262427C3 (de) Immunostimulierendes Mittel
EP1171107B1 (de) Verwendung einer pharmazeutischen zusammensetzung zur herstellung eines medikamentes zur behandlung von durch bakterien, viren, pilze, hefen und/oder protozoen verursachten augenerkrankungen
EP0263528B1 (de) Salmonella-Lebendimpfstoffe mit Wirtsspezies-angepassten Attenuierungshöhen und antiepidemischer Potenz
DE60213785T2 (de) Saponin inaktivierte mykoplasma impfstoffe
EP0642796A1 (de) Salmonella-Lebendimpfstoff
DE2854723C3 (de) Hetero-Impfstoff zur therapeutischen Behandlung des Trichomonas -Syndroms und Verfahren zu seiner Herstellung
DE833673C (de) Verfahren zur Herstellung einer Schweinecholera-Lymphe
DE2225548C3 (de) Intravenös verträglicher Impfstoff gegen Staupe- und Hepatite contagiosa canis
DE2700338C2 (de) Parenteral injizierbarer Impfstoff für Schweine gegen Infektionen von Bordetella bronchiseptica sowie Verfahren zum Herstellen dieses Impfstoffes
DE2165401C3 (de) Inaktivierter Kombinationsimpfstoff zum Immunisieren von Geflügel gegen Infektion der Atmungsorgane
DE2704767C2 (https=)
DE338166C (de) Verfahren zur Herstellung unschaedlicher Impfstoffe aus gifthaltigen pathogenen Mikroorganismen
DE940315C (de) Verfahren zur Herstellung von Lymphe gegen Schweinepest
EP0357585B1 (de) Gegen Pseudomonas aeruginosa-Infektionen wirksame Präparationen sowie Immunglobulin-G-hältige, gegen Bakterium Pseudomonas aeruginosa wirksame Präparationen
DE2437166C3 (de) Arzneimittel gegen interferonsensible, viralbedingte Infektionskrankheiten

Legal Events

Date Code Title Description
D2 Grant after examination
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee